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ABSTRACT
Craniofacial fibrous dysplasia is 1 of 3 types of
fibrous dysplasia that can affect the bones of the craniofacial
complex, including the mandible and maxilla.
Fibrous displasia is a skeletal developmental disorder
of the bone-forming mesenchyme that manifests as a defect
in osteoblastic differentiation and maturation.
It is a lesion of unknown etiology, uncertain
pathogenesis, and diverse histopathology.
Fibrous dysplasia represents about 2, 5% of all bone
tumors and over 7% of all benign tumours.
The aim of this article is to represent a rare case of
bilateral fibrous dysplasia of the upper and lower jaws, in
combination with Intellectual disability (previously called
mental retardation). The clinical diagnostic approach
including imaging studies: Orthopantomogram (OPG) and
3D tomography is described. Histological examination was
also essential for obtaining a definitive diagnosis.
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INTRODUCTION
Fibrous dysplasia (FD) is a bone development
anomaly characterized by hamartoma proliferation of fibrous
tissue within the medullary bone, with secondary bony
metaplasia, producing immature, newly formed and weakly
calcified bone, without maturation of the osteoblast which
appears radiolucent on radiographs, with the classically
described ground-glass appearance.(1).
In 1937, McCune and Bruch first suggested that
among all of the abnormalities of bone formation, this
disorder should have its own place as a distinct clinical
entity. The following year, Lichtenstein introduced the term
“fibrous dysplasia”
Reed’s definition states that fibrous dysplasia is an
arrest of bone maturation, woven bone with ossification
resulting from metaplasia of a nonspecific fibro osseous
type. (3). The etiology of this abnormal growth process is
related to a mutation in the gene that encodes the subunit
of a stimulatory G protein (Gsα ) located on chromosome
20.1,2 As a consequence of this mutation, there is a
substitution of the cysteine or the histidine-amino acids of
the genomic DNA in the osteoblastic cells-by another amino
acid, arginine.3 Consequently, the osteoblastic cells will
elaborate a fibrous tissue in the bone marrow instead of
normal bone. (8, 9, 10).
It is a benign bone disorder of an unknown etiology,
uncertain pathogenesis and diverse histopathology (2).
Fibrous dysplasia represents about 2, 5% of all bone
tumors and over 7% of all benign tumours
Cranial or facial bones are affected approximately in
30% of the patients. (3, 4). The average age of the patients
with FD is 25, 8 years (from 5 to 67) without sex
preference(46, 7%  male) and usually manifests before the
3rd decade of life. (4, 5)
 Fibrous dysplasia is described in terms of three
major types: monostotic, involving a single bone;
polyostotic, having multiple lesions involving multiple
bones; and McCune Albright syndrome, a polyostotic form
of fibrous dysplasia that also involves endocrine
abnormalities.
The monostotic form of fibrous dysplasia is the most
common, comprising 70% of cases, most likely to quiesce
at puberty. A typical monostotic lesion, usually presented
unilateral, will involve the femur, tibia or ribs, with 25%
occurring in the bones of the skull. Affection of the
craniofacial bone is observed with 10% of the patients
suffering from monostotic FD (6, 7).
Twenty-five percent of fibrous dysplasia involves two
or more bones. These lesions may be localized to one region
of the body or they may be disseminated, involving virtually
every bone. There is a female predilection in polyostotic
fibrous dysplasia, and up to 50% may involve bones in the
head and neck. These lesions are more likely to continue to
progress even after puberty.
Deformity is progressive and by mass effect there
may be impingement on other structures and functional
impairment.
These lesions tend to be structurally weak and are
therefore prone to pathologic fracture. Alkaline phosphatase
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may be elevated in up to 30% of patients with polyostotic
fibrous dysplasia, and a dramatic rise may herald malignant
degeneration.
Malignant degeneration occurs in less than 1% of
cases of fibrous dysplasia. Malignancies are almost
exclusively osteosarcoma. For unknown reasons, monostotic
and craniofacial lesions have the greatest potential for
malignant degeneration. Pain, rapid growth of a lesion and
a dramatic elevation of alkaline phosphatase may herald
malignant transformation.
CASE REPORT
A 28-year-old male presented at the Oral surgery
department, Medical university, Plovdiv six years ago with
complaining of mild pain in the lower jaw without precise
localization.
The past medical history includes skin disorder -
rosacea and medium Intellectual disability manifesting with
emotional-volitional instability prolonged neurotic
decompensation.
There was no family history with similar findings.
The general physical examination revealed a
moderately built patient with satisfactory vital signs and
mental retardation.
Extraorally no facial deformity was ascertained.
Picture 2.
Picture 1.
Oral examination revealed the presence of bilateral
symmetrical expansion in the distal part of the alveolar ridge
of lower and upper jaws.
Picture 3.
The covering and surrounding mucosa was normal in
color, without any clinical manifestation of inflammation or
ulceration.
On palpation affected areas was painless, with hard
consistence and plane surface.
The initial diagnosis based on the clinical
examination was fibrous dysplasia of the upper and lower
jaws.
Further Imaging Studies with X-ray and 3D
tomography was undertaken for accurately definition of the
bone density and for obtaining the definite diagnosis.
They confirmed lesion confined to the interior of
bone with no soft-tissue involvement witch was helpful in
distinguishing fibrous dysplasia from a malignancy.
Maxillary and mandibular involvement had a mixed
radiolucent and radiopaque pattern.
Orthopantomo graph revealed diffusive radiolucent
areas in the posterior areas of upper and lower jaws.12  / JofIMAB; Issue: vol. 16, book 4, 2010 /
Picture 4.
In the area of the lower left first molar above the
mandubular canal was observed radio opacity measuring
around 10 mm with obliteration of two third of the left
maxillary sinus.
DISCUSSION
Fibrous dysplasia of the cranium is a rare disorder
of unknown etiology in which normal bone is replaced by
abnormal fibro-connective tissue proliferation.
In 36, 3% of the cases of FD the clinical beginning
is hidden, there is no clear symptoms and obtaining the
diagnosis is complicated. The rest of the patients (63, 6%)
are with diverse symptoms depending on location, swelling,
deformation and presence of pain (8, 11).
Polyostotic fibrous dysplasia affects multitude
skeletal bones usually unilateral.
The patient at present is in quiescence and no bone
increase is detected during following years.
Sudden increase in the level of alkaline phosphatase
is one of the symptoms for malignant transformation and for
that reason its amount should be periodically observed.
At present alkaline phosphatase level is normal and
maintains a constant level.
The pain in the lower jaw, being the main complaint
of the patient, is considered to be caused by compression
of the mandible nerve of the enlarged fibrous tissue.
The main aim of the treatment is correction of the
functionality in combination with aesthetic effects.
Surgical excision of the affected bone tissue is usually
a successful way of treatment. However it leeds to a huge
functional and aesthetic deficit, as well as long-term post-
operative complications.
The conservative therapeutical approach with limited
reduction in the size of these lesions is enough to manage
the symptoms. Because patients with FD may be at risk of
malignant transformation, periodic follow-up is mandatory
to detect such transformation. (2, 13). Although the
conservative approach in case of FD, affecting the jaws, is
widespread, ortognatic surgery is used in many cases in
order to restore the occlusion and to correct the dentofacial
deformity, caused by the disorder.
Surgical approach aims:  stable occlusion, facial
aesthetics and evasion of post-operative relapse. The
radiotherapy is contra indicated (14, 15).
Biphosphonates are used in cases when an
intervention is necessary but the surgery can not be
performed (8). Some authors suggest applying calcitonin in
combination with surgical treatment. Calcitonin treatment
aims local bone calcification which leads to reduction in
bleeding during the bone remodeling (16).
Usually the prognosis is good although the bad
outcomes occur more frequently among young patients or
those with polyostotic forms of the disorder (8).  The
interval between the diagnosis of FD and the development
of malignity is 13,5 years. The risk of malignant
Picture 5.
During the extraction of the lower left first molar a
bone and soft tissue was taken for histological examination.
The histological findings (¹ 12924/ 7. 05. 2007)
showed fibrous modification of the bone tissue without soft
tissue involvement. This led to the definite diagnosis Fibrous
dysplasia.
The patient was advised to visit his dentist regularly
for ongoing re-examination and to observe and inform for
any change in growth formation and appearance of pain.
In the re-examine periodically is measured the level
of alkaline phosphatase.  / JofIMAB; Issue: vol. 16, book 4, 2010 /  13
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transformation is 0, 5%, if the patient with FD does not
undergo treatment (1, 8). The malignant transformation is
higher among male with polyostotic FD, craniofacial lesions
and monostotic FD. The clinical signs of malignity
development are: pain, immediate swelling and an increase
in the alkaline phosphatase. The radiotherapy increased
malignant transformations more than 400 times (1, 3).
CONCLUSIONS
Isolated cases of fibrous displasia in maxillo-
mandibular region are rare and can be difficult to
differentiate from other benign and malignant bone
disorders.
The general dental practitioner can be the first to
detect such conditions especially when the only affected
areas are in maxillo-mandibular region so sufficient
knowledge on this condition is important for the proper
diagnosis, treatment and prevention of further complications.
For obtaining the definite diagnosis, treatment and
further management of fibrous displasia is mandatory to be
carried out imaging studies, histological and laboratory tests.